Duodenal Ulcer Etiology and Management Guidelines
Primary Etiologic Factors
- Helicobacter pylori infection accounts for roughly three‑quarters of duodenal ulcers in the general population. 1
- Individuals infected with H. pylori have an estimated lifetime risk of about 17 % (≈1 in 6) of developing a peptic ulcer. 1
- H. pylori infection is typically acquired in childhood through family transmission, which explains familial clustering of ulcer disease. 1
NSAID‑Related Ulcer Etiology
- Non‑steroidal anti‑inflammatory drug (NSAID) use is the second leading cause of duodenal ulcer, contributing substantially to the overall burden of disease. 1
- Concurrent H. pylori infection in NSAID users amplifies the risk of upper‑gastrointestinal complications by 2‑ to 4‑fold. 2, 3
Risk Stratification for NSAID‑Related Ulcers
- History of prior ulcer disease or ulcer complications is the strongest predictor of NSAID‑induced ulceration. 3
- Advanced age independently increases the risk of NSAID‑related ulcer complications. 1
- Presence of cardiovascular disease further elevates ulcer risk in NSAID users. 2
- Concurrent use of aspirin, other antiplatelet agents, systemic corticosteroids, or anticoagulants adds additional risk. 3
Incidence of NSAID‑Related Ulcer Complications by Risk Profile
| Number of Risk Factors | Annualized Incidence of Ulcer Complications |
|---|---|
| 0 (no risk factors) | 0.8 % |
| 1 (single risk factor) | 2 % |
| 3 (three risk factors) | 7.6 %–8.6 % |
| 4 (four risk factors) | 18 % |
Incidence data derived from pooled analyses of NSAID‑using populations. 2, 1
Less Common Etiologies
- Recent antibiotic therapy can suppress H. pylori detection, potentially obscuring the true cause of ulceration. 1
- Pancreatic carcinoma invading the duodenum may present as a duodenal ulcer. 1
- Rare infections such as Gastrospirillum hominis have been reported as ulcerogenic agents. 1
Clinical Recommendations
- All patients who require ongoing NSAID therapy should be screened for H. pylori infection because eradication markedly reduces the synergistic risk of ulcer complications. 2, 3
- Eradication of H. pylori infection prevents ulcer recurrence and the development of new duodenal ulcers, shifting the disease paradigm from chronicity to curability. 1
- Population‑level declines in H. pylori prevalence have contributed to a reduction in overall peptic ulcer disease incidence in developed regions. 1